IP Library › Granted Patent US 12,706,180
Granted Patent B2
US 12,706,180 · App. 19/251,587 · Granted Aug 11, 2026

System and method for management of compressed sequencing files

Inventor: Alexander Halley Stram (Altadena, CA)
Assignee: Personalis, Inc.
G16B50/50G06F16/174G06N3/04G16B20/00G16B30/10G16B50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,706,180
App. No.
19/251,587
Filed
Jun 26, 2025
Granted
Aug 11, 2026
Kind
B2
Art Unit
2845
USPC
341/50
Abstract

Systems and methods for management of storing and analyzing genetic sequencing data. In some embodiments disclosed herein, a method for converting a compressed SAM file back into a raw FASTQ file, wherein the information of the raw FASTQ file is substantively identical to that which was stored in the original FASTQ file from which the compressed SAM file is based is provided. The method advantageously enables storage of the smaller compressed SAM files for reliable, efficient reconstruction of the original FASTQ file when needed.

Claims (44)

1 . A method of regenerating a FASTQ file from a compressed sequence alignment map file, the compressed sequence alignment map file including alignment data for a plurality of sequence strings for more than one aligned reads of clusters on a flow cell, the method comprising:

(a) determining an fqsum of an original FASTQ file on which the compressed sequence alignment file is based, wherein each entry of the original FASTQ file is defined by at least four line-separated fields per sequence and the fqsum represents an order invariant checksum of the original FASTQ file;

(b) storing a quality score of each base call for individual instances of the plurality of sequence strings;

(c) sorting the compressed sequence alignment map file by one or more reference genome coordinates;

(d) extracting primary alignments from the compressed sequence alignment map file;

(e) ensuring all FASTQ records from the original FASTQ file are stored in the compressed SAM file;

(f) reconstructing original base quality scores by at least one of retrieving the stored quality score or applying an inverse of a model of the stored quality score;

(g) writing at least three of the four line-separated fields per sequence of the compressed sequence alignment map file to a regenerated FASTQ file; and

(h) compressing the regenerated FASTQ file.

2 . The method of claim 1 , further comprising comparing the determined fqsum with an fqsum of the regenerated FASTQ file.

3 . The method of claim 1 , wherein said determining the fqsum of the original FASTQ file further comprises: for a set A and a set B of the original FASTQ file, fqsum ({A})=fqsum (fqsum ({A})), fqsum ({A, B})=fqsum ({B, A}), and fqsum({fqsum ({A, B}), C})=fqsum ({A, fqsum({B, C})}).

4 . The method of claim 1 , wherein said storing the quality score comprises generating a base quality score recalibration model.

5 . The method of claim 1 , wherein said storing the quality score of each base call for individual instances of the plurality of sequence strings comprises storing a Phred scaled score.

6 . The method of claim 5 , wherein said storing the quality score of each base call for individual instances of the plurality of sequence strings comprises storing a string of integers, equal in length to a selected sequence string of the plurality of sequence strings.

7 . The method of claim 1 , wherein said ensuring all FASTQ records from the original FASTQ file are stored in the compressed SAM file further comprises: (i) removing sequencing duplicates and off-target reads, and (ii) storing the sequencing duplicates and off-target reads in an auxiliary compressed sequence alignment map file.

8 . The method of claim 1 , wherein the at least four line-separated fields per sequence of each entry of the original FASTQ file comprises: (i) a sequence identifier field, (ii) a sequence field, (iii) a quality score identifier field, and (iv) a quality score field.

9 . The method of claim 1 , wherein the compressed sequence alignment map file comprises at least one of a binary alignment map file and a compressed reference-oriented map file.

10 . The method of claim 1 , wherein a file size of the compressed sequence alignment map file is smaller than a file size of either of the original FASTQ file and the regenerated FASTQ file.

11 . A method of regenerating a FASTQ file from a compressed sequence alignment map file, the compressed sequence alignment map file including alignment data for a plurality of sequence strings for more than one aligned reads of clusters on a flow cell, the method comprising:

(a) determining an fqsum of an original FASTQ file on which the compressed sequence alignment file is based, wherein each entry of the original FASTQ file is defined by at least four line-separated fields per sequence and the fqsum represents an order invariant checksum of the original FASTQ file;

(b) storing a quality score of each base call for individual instances of the plurality of sequence strings;

(c) sorting the compressed sequence alignment map file by sequence string;

(d) extracting primary alignments from the compressed sequence alignment map file;

(e) ensuring all FASTQ records from the original FASTQ file are stored in the compressed SAM file;

(f) reconstructing original base quality scores by at least one of retrieving the stored quality score or applying an inverse of a model of the stored quality score;

(g) writing at least three of the four line-separated fields per sequence of the compressed sequence alignment map file to a regenerated FASTQ file; and

(h) compressing the regenerated FASTQ file.

12 . The method of claim 11 , further comprising comparing the determined fqsum with an fqsum of the regenerated FASTQ file.

13 . The method of claim 11 , wherein said determining the fqsum of the original FASTQ file further comprises: for a set A and a set B of the original FASTQ file, fqsum ({A})=fqsum (fqsum ({A})), fqsum ({A, B})=fqsum ({B, A}), and fqsum({fqsum ({A, B}), C})=fqsum ({A, fqsum({B, C})}).

14 . The method of claim 11 , wherein said storing the quality score comprises generating a base quality score recalibration model.

15 . The method of claim 11 , wherein said storing the quality score of each base call for individual instances of the plurality of sequence strings comprises storing a Phred scaled score.

16 . The method of claim 15 , wherein said storing the quality score of each base call for individual instances of the plurality of sequence strings comprises storing a string of integers, equal in length to a selected sequence string of the plurality of sequence strings.

17 . The method of claim 11 , wherein the at least four line-separated fields per sequence of each entry of the original FASTQ file comprises: (i) a sequence identifier field, (ii) a sequence field, (iii) a quality score identifier field, and (iv) a quality score field.

18 . The method of claim 10 , wherein the compressed sequence alignment map file comprises at least one of a binary alignment map file and a compressed reference-oriented map file.

19 . The method of claim 11 , wherein a file size of the compressed sequence alignment map file is smaller than a file size of either of the original FASTQ file and the regenerated FASTQ file.

20 . A computer program product for regenerating a FASTQ file from a compressed sequence alignment map file, the compressed sequence alignment map file including alignment data for a plurality of sequence strings for more than one aligned reads of clusters on a flow cell, the computer program product being encoded on one or more machine-readable storage media and comprising instructions for:

(i) determining an fqsum of an original FASTQ file on which the compressed sequence alignment file is based, wherein each entry of the original FASTQ file is defined by at least four line-separated fields per sequence and the fqsum represents an order invariant checksum of the original FASTQ file;

(ii) storing a quality score of each base call for individual instances of the plurality of sequence strings;

(iii) sorting the compressed sequence alignment map file by one or more reference genome coordinates;

(iv) extracting primary alignments from the compressed sequence alignment map file;

(v) ensuring all FASTQ records from the original FASTQ file are stored in the compressed SAM file;

(vi) reconstructing original base quality scores by at least one of retrieving the stored quality score or applying an inverse of a model of the stored quality score;

(vii) writing at least three of the four line-separated fields per sequence of the compressed sequence alignment map file to a regenerated FASTQ file; and

(viii) compressing the regenerated FASTQ file.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2026
From: STRAM, ALEXANDER HALLEY
To: PERSONALIS, INC.
Reel/Frame 074439/0104 →
Continuity (2)
Provisional Application 63665079 · Jun 27, 2024
Related Publication 20260004886A1 · Jan 1, 2026
References Cited (400)
US 4458066A · Caruthers et al. · 1984 [cited by applicant]
US 4683202A · Mullis · 1987 [cited by applicant]
US 4988617A · Landegren et al. · 1991 [cited by applicant]
US 5143854A · Pirrung et al. · 1992 [cited by applicant]
US 5242794A · Whiteley et al. · 1993 [cited by applicant]
US 5299491A · Kawada · 1994 [cited by applicant]
US 5382510A · Levine et al. · 1995 [cited by applicant]
US 5403708A · Brennan et al. · 1995 [cited by applicant]
US 5412087A · McGall et al. · 1995 [cited by applicant]
US 5432065A · Fuller · 1995 [cited by applicant]
US 5472672A · Brennan · 1995 [cited by applicant]
US 5494810A · Barany et al. · 1996 [cited by applicant]
US 5641658A · Adams et al. · 1997 [cited by applicant]
US 5928907A · Woudenberg et al. · 1999 [cited by applicant]
US 6015674A · Woudenberg et al. · 2000 [cited by applicant]
US 6045996A · Cronin et al. · 2000 [cited by applicant]
US 6156504A · Gocke et al. · 2000 [cited by applicant]
US 6420117B1 · Wessler et al. · 2002 [cited by applicant]
US 6582938B1 · Su et al. · 2003 [cited by applicant]
US 6754655B1 · Segal · 2004 [cited by applicant]
US 6818395B1 · Quake et al. · 2004 [cited by applicant]
US 7169560B2 · Lapidus et al. · 2007 [cited by applicant]
US 7211390B2 · Rothberg et al. · 2007 [cited by applicant]
US 7211654B2 · Gao et al. · 2007 [cited by applicant]
US 7244559B2 · Rothberg et al. · 2007 [cited by applicant]
US 7264929B2 · Rothberg et al. · 2007 [cited by applicant]
US 7280922B2 · Mei et al. · 2007 [cited by applicant]
US 7282337B1 · Harris · 2007 [cited by applicant]
US 7300788B2 · Matsuzaki et al. · 2007 [cited by applicant]
US 7323305B2 · Leamon et al. · 2008 [cited by applicant]
US 7335762B2 · Rothberg et al. · 2008 [cited by applicant]
US 7361488B2 · Fan et al. · 2008 [cited by applicant]
US 7534561B2 · Sana et al. · 2009 [cited by applicant]
US 7582420B2 · Oliphant et al. · 2009 [cited by applicant]
US 7785783B2 · Morley et al. · 2010 [cited by applicant]
US 7803550B2 · Makarov et al. · 2010 [cited by applicant]
US 8026094B2 · Green et al. · 2011 [cited by applicant]
US 8133719B2 · Drmanac et al. · 2012 [cited by applicant]
US 8140270B2 · Kingsmore et al. · 2012 [cited by applicant]
US 8296076B2 · Fan et al. · 2012 [cited by applicant]
US 8318430B2 · Chuu et al. · 2012 [cited by applicant]
US 8323897B2 · Andersen et al. · 2012 [cited by applicant]
US 8415101B2 · Garner · 2013 [cited by applicant]
US 8417459B2 · Reese et al. · 2013 [cited by applicant]
US 8532930B2 · Rabinowitz et al. · 2013 [cited by applicant]
US 8589175B2 · Glauser et al. · 2013 [cited by applicant]
US 8785353B2 · Van Eijk et al. · 2014 [cited by applicant]
US 8862410B2 · Hatchwell et al. · 2014 [cited by applicant]
US 9051602B2 · Oliphant et al. · 2015 [cited by applicant]
US 9109256B2 · Shuber · 2015 [cited by applicant]
US 9128861B2 · Bartha et al. · 2015 [cited by applicant]
US 9183496B2 · Harris et al. · 2015 [cited by applicant]
US 9228232B2 · Faham et al. · 2016 [cited by applicant]
US 9329170B2 · Clarke et al. · 2016 [cited by applicant]
US 9416422B2 · Cheung · 2016 [cited by applicant]
US 9453257B2 · Hoyal-Wrightson et al. · 2016 [cited by applicant]
US 9512485B2 · Richardson et al. · 2016 [cited by applicant]
US 9523121B2 · Spier et al. · 2016 [cited by applicant]
US 9725755B2 · Poole et al. · 2017 [cited by applicant]
US 9727692B2 · Harris et al. · 2017 [cited by applicant]
US 9745626B2 · Bartha et al. · 2017 [cited by applicant]
US 9909186B2 · Schuetz et al. · 2018 [cited by applicant]
US 10017810B2 · Iafrate et al. · 2018 [cited by applicant]
US 10032000B1 · Harris et al. · 2018 [cited by applicant]
US 10125399B2 · West · 2018 [cited by applicant]
US 10174375B2 · Lo et al. · 2019 [cited by applicant]
US 10255330B2 · Chandratillake et al. · 2019 [cited by applicant]
US 10262103B2 · Lehrer et al. · 2019 [cited by applicant]
US 10266890B2 · Bartha et al. · 2019 [cited by applicant]
US 10344318B2 · May et al. · 2019 [cited by applicant]
US 10415091B2 · Bartha et al. · 2019 [cited by applicant]
US 10450611B2 · West et al. · 2019 [cited by applicant]
US 10590468B2 · Pedersen et al. · 2020 [cited by applicant]
US 10597717B2 · Maguire et al. · 2020 [cited by applicant]
US 10711306B2 · Shiina et al. · 2020 [cited by applicant]
US 10738355B2 · Sahin et al. · 2020 [cited by applicant]
US 10741269B2 · Chudova et al. · 2020 [cited by applicant]
US 10801064B2 · West et al. · 2020 [cited by applicant]
US 10801070B2 · Clement et al. · 2020 [cited by applicant]
US 10900088B2 · Volgelstein et al. · 2021 [cited by applicant]
US 11047006B2 · Salk et al. · 2021 [cited by applicant]
US 11062789B2 · Chiu et al. · 2021 [cited by applicant]
US 11124824B2 · Sarwal et al. · 2021 [cited by applicant]
US 11142797B2 · Moynahan et al. · 2021 [cited by applicant]
US 11155867B2 · Bartha et al. · 2021 [cited by applicant]
US 11286530B2 · Rabinowitz et al. · 2022 [cited by applicant]
US 11345968B2 · Mortimer et al. · 2022 [cited by applicant]
US 11840730B1 · Porreca et al. · 2023 [cited by applicant]
US 12203142B2 · Babiarz et al. · 2025 [cited by applicant]
US 20020006615A1 · Goldsborough et al. · 2002 [cited by applicant]
US 20020164629A1 · Quake et al. · 2002 [cited by applicant]
US 20030022200A1 · Vissing et al. · 2003 [cited by applicant]
US 20030096011A1 · Tracy et al. · 2003 [cited by applicant]
US 20030099964A1 · Patil et al. · 2003 [cited by applicant]
US 20030100995A1 · Loraine et al. · 2003 [cited by applicant]
US 20030220777A1 · Kitchen et al. · 2003 [cited by applicant]
US 20050042668A1 · Perlin · 2005 [cited by applicant]
US 20050086035A1 · Peccoud et al. · 2005 [cited by applicant]
US 20050125474A1 · Pednault · 2005 [cited by applicant]
US 20050250125A1 · Novakoff · 2005 [cited by applicant]
US 20050260645A1 · Green et al. · 2005 [cited by applicant]
US 20060184489A1 · Weiner et al. · 2006 [cited by applicant]
US 20060278241A1 · Ruano · 2006 [cited by applicant]
US 20070111247A1 · Stephens et al. · 2007 [cited by applicant]
US 20070184436A1 · Myerson et al. · 2007 [cited by applicant]
US 20080096766A1 · Lee · 2008 [cited by applicant]
US 20080305473A1 · Chowdary et al. · 2008 [cited by applicant]
US 20090026082A1 · Rothberg et al. · 2009 [cited by applicant]
US 20090029364A1 · Zirwes et al. · 2009 [cited by applicant]
US 20090127589A1 · Rothberg et al. · 2009 [cited by applicant]
US 20090183268A1 · Kingsmore · 2009 [cited by applicant]
US 20090191565A1 · Lapidus et al. · 2009 [cited by applicant]
US 20090326832A1 · Heckerman et al. · 2009 [cited by applicant]
US 20100029498A1 · Gnirke et al. · 2010 [cited by applicant]
US 20100035252A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100042438A1 · Moore et al. · 2010 [cited by applicant]
US 20100137143A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100188073A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100197507A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100282617A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100300559A1 · Schultz et al. · 2010 [cited by applicant]
US 20100300895A1 · Nobile et al. · 2010 [cited by applicant]
US 20100301398A1 · Rothberg et al. · 2010 [cited by applicant]
US 20100304982A1 · Hinz et al. · 2010 [cited by applicant]
US 20110004413A1 · Carnevali et al. · 2011 [cited by applicant]
US 20110009296A1 · Kain et al. · 2011 [cited by applicant]
US 20110105353A1 · Lo et al. · 2011 [cited by applicant]
US 20110184896A1 · Guyon · 2011 [cited by applicant]
US 20120015050A1 · Abkevich et al. · 2012 [cited by applicant]
US 20120058480A1 · Lewis et al. · 2012 [cited by applicant]
US 20120077682A1 · Bowcock et al. · 2012 [cited by applicant]
US 20120116688A1 · Mishra et al. · 2012 [cited by applicant]
US 20120143512A1 · Reese et al. · 2012 [cited by applicant]
US 20120208706A1 · Downing et al. · 2012 [cited by applicant]
US 20120270206A1 · Ginns et al. · 2012 [cited by applicant]
US 20120270212A1 · Rabinowitz et al. · 2012 [cited by applicant]
US 20120295810A1 · Quake et al. · 2012 [cited by applicant]
US 20130073217A1 · Dewey et al. · 2013 [cited by applicant]
US 20130090908A1 · Dewey et al. · 2013 [cited by applicant]
US 20130096011A1 · Rava et al. · 2013 [cited by applicant]
US 20130102477A1 · Morin et al. · 2013 [cited by applicant]
US 20130124100A1 · Drmanac et al. · 2013 [cited by applicant]
US 20130173177A1 · Pelleymounter · 2013 [cited by applicant]
US 20130178389A1 · Lapidus et al. · 2013 [cited by applicant]
US 20130261196A1 · Diamond et al. · 2013 [cited by applicant]
US 20130296535A1 · Church et al. · 2013 [cited by applicant]
US 20130311448A1 · Thompson · 2013 [cited by applicant]
US 20130332081A1 · Reese et al. · 2013 [cited by applicant]
US 20140186827A1 · Pieprzyk et al. · 2014 [cited by applicant]
US 20140200147A1 · Bartha et al. · 2014 [cited by applicant]
US 20150051087A1 · Rabinowitz et al. · 2015 [cited by applicant]
US 20150057160A1 · Breuer et al. · 2015 [cited by applicant]
US 20150066824A1 · Harris et al. · 2015 [cited by applicant]
US 20160019341A1 · Harris et al. · 2016 [cited by applicant]
US 20160032396A1 · Diehn et al. · 2016 [cited by applicant]
US 20160041987A1 · Lapir et al. · 2016 [cited by applicant]
US 20160092631A1 · Yandell et al. · 2016 [cited by applicant]
US 20160122831A1 · West · 2016 [cited by applicant]
US 20160283484A1 · Chandratillake et al. · 2016 [cited by applicant]
US 20170060896A1 · Ito et al. · 2017 [cited by applicant]
US 20170147597A1 · Leighton et al. · 2017 [cited by applicant]
US 20170166981A1 · Craig et al. · 2017 [cited by applicant]
US 20170199961A1 · Yelensky et al. · 2017 [cited by applicant]
US 20170253921A1 · Liu et al. · 2017 [cited by applicant]
US 20170316150A1 · Deciu et al. · 2017 [cited by applicant]
US 20170356053A1 · Otto et al. · 2017 [cited by applicant]
US 20180051338A1 · West et al. · 2018 [cited by applicant]
US 20180127807A1 · Stahl et al. · 2018 [cited by applicant]
US 20180203974A1 · Venn · 2018 [cited by applicant]
US 20180258489A1 · Danenberg · 2018 [cited by applicant]
US 20180282801A1 · Zhao et al. · 2018 [cited by applicant]
US 20180363066A1 · Chalmers et al. · 2018 [cited by applicant]
US 20190127803A1 · Hacohen et al. · 2019 [cited by applicant]
US 20190153541A1 · Lo et al. · 2019 [cited by applicant]
US 20190189242A1 · Angiuoli et al. · 2019 [cited by applicant]
US 20190211406A1 · Babiarz et al. · 2019 [cited by applicant]
US 20190285518A1 · Lu et al. · 2019 [cited by applicant]
US 20190346442A1 · Carr et al. · 2019 [cited by applicant]
US 20200024669A1 · Spetzler et al. · 2020 [cited by applicant]
US 20200048711A1 · Snyder · 2020 [cited by applicant]
US 20200058377A1 · Bagaev et al. · 2020 [cited by applicant]
US 20200105378A1 · Abelin et al. · 2020 [cited by applicant]
US 20200149097A1 · Otto et al. · 2020 [cited by applicant]
US 20200157604A1 · Plagnol et al. · 2020 [cited by applicant]
US 20200202224A1 · Lanman et al. · 2020 [cited by applicant]
US 20200258597A1 · Perera · 2020 [cited by applicant]
US 20200258601A1 · Lau · 2020 [cited by applicant]
US 20200392584A1 · Almogy et al. · 2020 [cited by applicant]
US 20210054452A1 · West et al. · 2021 [cited by applicant]
US 20210062258A1 · Bartha et al. · 2021 [cited by applicant]
US 20210062276A1 · West · 2021 [cited by applicant]
US 20210210205A1 · Drake et al. · 2021 [cited by applicant]
US 20210238677A1 · Bartha et al. · 2021 [cited by applicant]
US 20210257052A1 · Rooyen et al. · 2021 [cited by applicant]
US 20210304841A1 · Renzi · 2021 [cited by examiner]
US 20210363586A1 · Artsiomenka et al. · 2021 [cited by applicant]
US 20210398609A1 · Sigurjonsson et al. · 2021 [cited by applicant]
US 20220004847A1 · Mapiye et al. · 2022 [cited by applicant]
US 20220064733A1 · Alexander et al. · 2022 [cited by applicant]
US 20220073985A1 · Nerenberg et al. · 2022 [cited by applicant]
US 20220081716A1 · West et al. · 2022 [cited by applicant]
US 20220195530A1 · Diehn et al. · 2022 [cited by applicant]
US 20220344005A1 · Molyneaux et al. · 2022 [cited by applicant]
US 20240134825A1 · Nazari · 2024 [cited by examiner]
CN 105044108A · 2015 [cited by applicant]
CN 109903811A · 2019 [cited by applicant]
EP 0281927B1 · 1995 [cited by applicant]
EP 1342794B1 · 2005 [cited by applicant]
EP 2861788B1 · 2018 [cited by applicant]
EP 3212808B1 · 2022 [cited by applicant]
WO 2000018957A1 · 2000 [cited by applicant]
WO 2005098046A2 · 2005 [cited by applicant]
WO 2007055244A1 · 2007 [cited by applicant]
WO 2010054589A1 · 2010 [cited by applicant]
WO 2011050341A1 · 2011 [cited by applicant]
WO 2011057061A1 · 2011 [cited by applicant]
WO 2011057094A1 · 2011 [cited by applicant]
WO 2011091046A1 · 2011 [cited by applicant]
WO 2011149534A2 · 2011 [cited by applicant]
WO 2011160063A2 · 2011 [cited by applicant]
WO 2011160206A1 · 2011 [cited by applicant]
WO 2012142611A2 · 2012 [cited by applicant]
WO 2014053295A1 · 2014 [cited by applicant]
WO 2014062717A1 · 2014 [cited by applicant]
WO 2014113204A1 · 2014 [cited by applicant]
WO 2014207245A1 · 2014 [cited by applicant]
WO 2015051275A1 · 2015 [cited by applicant]
WO 2015095889A2 · 2015 [cited by applicant]
WO 2016070131A1 · 2016 [cited by applicant]
WO 2017205823A1 · 2017 [cited by applicant]
WO 2018053365A1 · 2018 [cited by applicant]
WO 2018064547A1 · 2018 [cited by applicant]
WO 2018144782A1 · 2018 [cited by applicant]
WO 2018195357A1 · 2018 [cited by applicant]
WO 2018222883A1 · 2018 [cited by applicant]
WO 2019168984A1 · 2019 [cited by applicant]
WO 2019226939A1 · 2019 [cited by applicant]
WO 2019231856A1 · 2019 [cited by applicant]
WO 2020132586A1 · 2020 [cited by applicant]
WO 2020168008A1 · 2020 [cited by applicant]
WO 2020252721A1 · 2020 [cited by applicant]
WO 2021016089A1 · 2021 [cited by applicant]
WO 2022046947A1 · 2022 [cited by applicant]
Ralph et al. “Consistency of VDJ rearrangement and substitution parameters enables accurate B cell receptor sequence annotation.” PLoS computational biology 12.1 (2016): 1-25. [cited by applicant]
Riaz et al. “Tumor and microenvironment evolution during immunotherapy with nivolumab.” Cell 171.4 (2017): 934-949. [cited by applicant]
Richter, S. “Fecal DNA screening in colorectal cancer.” Canadian Journal of Gastroenterology and Hepatology 22.7 (2008): 631-633. [cited by applicant]
Riester et al. “PureCN: copy number calling and SNV classification using targeted short read sequencing.” Source Code for Biology and Medicine 11.13 (2016): 1-13. [cited by applicant]
Roberts et al. “The predictive capacity of personal genome sequencing.” Science translational medicine 4.133 (2012): 1-9. [cited by applicant]
Robinson et al. “Strategies for exome and genome sequence data analysis in disease-gene discovery projects.” Clinical genetics 80.2 (2011): 127-132. [cited by applicant]
Robinson et al. “The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.” The American Journal of Human Genetics 83.5 (2008): 610-615. [cited by applicant]
Rogozin et al. “Somatic mutation hotspots correlate with DNA polymerase n error spectrum.” Nature immunology 2.6 (2001): 530-536. [cited by applicant]
Rosenfeld et al. “Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing.” Nucleic acids research 38.18 (2010): 6102-6111. [cited by applicant]
Ross et al. “Characterizing and measuring bias in sequence data.” Genome biology 14 (2013): 1-20. [cited by applicant]
Ross et al. “Whole cancer genome sequencing by next-generation methods.” American journal of clinical pathology 136.4 (2011): 527-539. [cited by applicant]
Ross, D. “Introduction to oncogenes and molecular cancer medicine.” Springer Science & Business Media (1998): 1-10. [cited by applicant]
Saeys et al. “A review of feature selection techniques in bioinformatics.” Bioinformatics 23.19 (2007): 2507-2517. [cited by applicant]
Sahraeian et al. “Deep convolutional neural networks for accurate somatic mutation detection.” Nature communications 10.1 (2019): 1-10. [cited by applicant]
Saiki et al. “Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.” Nature 324.6093 (1986): 163-166. [cited by applicant]
Sambrook et al. “Molecular cloning: A Laboratory Manual.” 4th ed, 448 (2012): 1-26. [cited by applicant]
Samuels et al. “Genetic mosaics and the germ line lineage.” Genes 6.2 (2015): 216-237. [cited by applicant]
Sandri et al. “Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise.” FEBS letters 373.3 (1995): 291-295. [cited by applicant]
Saunders et al. “Strelka: accurate somatic small-variant calling from sequenced tumor normal sample pairs.” Bioinformatics 28.14 (2012): 1811-1817. [cited by applicant]
Schmitt et al. “Detection of ultra-rare mutations by next-generation sequencing.” Proceedings of the National Academy of Sciences 109.36 (2012): 14508-14513. [cited by applicant]
Schwarzenbach et al. “Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.” Annals of the New York Academy of Sciences 1137.1 (2008): 190-196. [cited by applicant]
Scitable. “Mendelian Trait.” Scitable by Nature Education, 2014. Retrieved from the Internet: <URL:https://web.archive.org/web/20140825124707/https://www.nature.com/scitable/definition/mendelian-trait-174/>, 2 pages. [cited by applicant]
Sequence Alignment/Map Format Specification, Manual [online], The SAM/BAM Format Specification Working Group, 2024. Retrieved from the Internet: <URL:https://samtools.github.io/hts-specs/SAMv1.pdf>, 23 pages. [cited by applicant]
Shapiro, E. “The human cell lineage flagship initiative.” Lineage-flagship.eu, 2010. Retrieved from the Internet: <URL:http://www.lineage-flagship.eu/>, 1 page. [cited by applicant]
Shaw et al. “Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.” Genome research 22.2 (2012): 220-231. [cited by applicant]
Shendure et al. “Next-generation DNA sequencing.” Nature biotechnology 26.10 (2008): 1135-1145. [cited by applicant]
Shigemizu et al. “A practical method to detect SNVs and indels from whole genome and exome sequencing data.” Scientific reports 3.1 (2013): 1-6. [cited by applicant]
Shigemizu et al. “A practical method to detect SNVs and indels from whole genome and exome sequencing data.” Supplementary Information. Scientific reports 3.1 (2013): 1-3. [cited by applicant]
Shim et al. “HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L) 1 blockade in advanced non-small-cell lung cancer patients.” Annals of Oncology 31.7 (202… [cited by applicant]
Sims et al. “Sequencing depth and coverage: key considerations in genomic analyses.” Nature Reviews Genetics 15.2 (2014): 121-132. [cited by applicant]
Singleton et al. “Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families.” The American Journal of Human Genetics 94.4 (201… [cited by applicant]
Smyth, G. “Limma: linear models for microarray data.” Bioinformatics and computational biology solutions using R and Bioconductor. New York, NY: Springer New York (2005): 397-420. [cited by applicant]
Snyder et al. “Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.” New England Journal of Medicine (2014): 1-11. [cited by applicant]
Song et al. “A reference methylome database and analysis pipeline to facilitate integrative and comparative epigenomics.” PloS one 8.12 (2013): 1-9. [cited by applicant]
Soni et al. “Progress toward ultrafast DNA sequencing using solid-state nanopores.” Clinical chemistry 53.11 (2007): 1996-2001. [cited by applicant]
Spalding et al. “Retrospective birth dating of cells in humans.” Cell 122.1 (2005): 133-143. [cited by applicant]
Stemmer et al. “Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.” Gene 164.1 (1995): 49-53. [cited by applicant]
Stevanovic et al. “Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.” Science 356.6334 (2017): 200-205. [cited by applicant]
Sudhakar et al. “Characterization of clonal immunoglobulin heavy (IGH) VDJ gene rearrangements and the complementarity-determining region in South Indian patients with precursor B-cell acute lymphoblastic leukemia.” Blo… [cited by applicant]
Sulston et al. “Post-embryonic cell lineages of the nematode, Caenorhabditis elegans.” Developmental biology 56.1 (1977): 110-156. [cited by applicant]
Sulston et al. “The embryonic cell lineage of the nematode Caenorhabditis elegans.” Developmental biology 100.1 (1983): 64-119. [cited by applicant]
Summerer et al. “Targeted high throughput sequencing of a cancer-related exome subset by specific sequence capture with a fully automated microarray platform.” Genomics 95.4 (2010): 241-246. [cited by applicant]
Sun et al. “Optimized data representation and convolutional neural network model for predicting tumor purity.” bioRxiv (2019): 1-9. [cited by applicant]
Sung et al. “Assessment of intratumoral heterogeneity with mutations and gene expression profiles.” PLoS One 14.7 (2019): 1-15. [cited by applicant]
SVBio. “SVBio's Services.” Company Information [online], SVBio, 2014. Retrieved from the Internet: <URL:http:www.svbio.com/service-offerings/current-services>, 1 page. [cited by applicant]
Swanton, C. “Plasma-derived tumor DNA analysis at whole-genome resolution.” Clinical Chemistry 59.1 (2013): 6-8. [cited by applicant]
Teer et al. “Exome sequencing: the sweet spot before whole genomes.” Human molecular genetics 19.R2 (2010): R145-R151. [cited by applicant]
Tests and Procedures: Urine cytology, Definition [online], Mayo Clinic, 2014 [retrieved on Dec. 1, 2015]. Retrieved from the Internet: <URL:http://www.mayoclinic.org/tests-procedures/urine-cytology/basics/definition/prc… [cited by applicant]
Tewhey et al. “Microdroplet-based PCR enrichment for large-scale targeted sequencing.” Nature biotechnology 27.11 (2009): 1025-1031. [cited by applicant]
Tug et al. “Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage.” Exercise immunology review 21 (2015): 164-173. [cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Genome research 22.2 (2012): 196-207. [cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Supplementary Figures. Genome research 22.2 (2012): 1-43. [cited by applicant]
Turajlic et al. “Whole genome sequencing of matched primary and metastatic acral melanomas.” Supplementary Tables. Genome research 22.2 (2012): 1-532. [cited by applicant]
Vaisvila et al. “EM-seq: detection of DNA methylation at single base resolution from picograms of DNA.” BioRxiv (2019): 1-38. [cited by applicant]
Valadi et al. “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.” Nature cell biology 9.6 (2007): 654-659. [cited by applicant]
Vale et al. “Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.” Cancer treatment reviews 38.6 (2012): 618-625. [cited by applicant]
Van Driel et al. “A text-mining analysis of the human phenome.” European journal of human genetics 14.5 (2006): 535-542. [cited by applicant]
Varscan. “Variant Detection in Massively Parallel Sequencing Data.” VarScan, 2009. Retrieved from the Internet: <URL:www.varscan.sourceforge.net.>, 4 pages. [cited by applicant]
Vasan, R. “Biomarkers of cardiovascular disease: molecular basis and practical considerations.” Circulation 113.19 (2006): 2335-2362. [cited by applicant]
Velculescu et al. “Characterization of the yeast transcriptome.” Cell 88.2 (1997): 243-251. [cited by applicant]
Velculescu et al. “Serial analysis of gene expression.” Science 270.5235 (1995): 484-487. [cited by applicant]
Vietsch et al. “Circulating DNA and micro-RNA in patients with pancreatic cancer.” Pancreatic disorders & therapy 5.2 (2015): 1-17. [cited by applicant]
Vinay et al. “Immune evasion in cancer: Mechanistic basis and therapeutic strategies.” Seminars in cancer biology. vol. 35. Academic Press (2015): S185-S198. [cited by applicant]
Vincent et al. “Helicase-dependent isothermal DNA amplification.” EMBO reports 5.8 (2004): 795-800. [cited by applicant]
Vos et al. “AFLP: a new technique for DNA fingerprinting.” Nucleic acids research 23.21 (1995): 4407-4414. [cited by applicant]
Wagle et al. “High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.” Cancer discovery 2.1 (2012): 82-93. [cited by applicant]
Walker et al. “Strand displacement amplification an isothermal, in vitro DNA amplification technique.” Nucleic acids research 20.7 (1992): 1691-1696. [cited by applicant]
Wang et al. “Clonal evolution in breast cancer revealed by single nucleus genome sequencing.” Nature 512.7513 (2014): 155-160. [cited by applicant]
Wang, K. “ANNOVAR Documentation.” Datasheet [online], ANNOVAR, 2010. Retrieved from the Internet: <URL: https://annovar.openbioinformatics.org/en/latest/>, 7 pages. [cited by applicant]
Warren et al. “Targeted assembly of short sequence reads.” PloS one 6.5 (2011): 1-6. [cited by applicant]
Wasserstrom et al. “Reconstruction of cell lineage trees in mice.” PloS one 3.4 (2008): 1-11. [cited by applicant]
Westin et al. “Anchored multiplex amplification on a microelectronic chip array.” Nature Biotechnology 18.2 (2000): 199-204. [cited by applicant]
Wikipedia. “Gradient boosting.” Wikipedia, 2020. Retrieved from the Internet: <URL:https://en.wikipedia.org/w/index.php?title=Gradient_boosting&oldid=957594903>, 8 pages. [cited by applicant]
Wright et al. “The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.” Human reproduction update 15.1 (2009): 139-151. [cited by applicant]
Xiao et al. “Identifying mRNA, microRNA and protein profiles of melanoma exosomes.” PLoS One 7.10 (2012): 1-15. [cited by applicant]
Yang et al. “Clinical whole-exome sequencing for the diagnosis of mendelian disorders.” New England Journal of Medicine 369.16 (2013): 1502-1511. [cited by applicant]
Yeung et al. “LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.” Clinical Cancer Research 19.7 (2013): 1816-1826. [cited by applicant]
Yi et al. “Sequencing of fifty human exomes reveals adaptation to high altitude.” Science 329.5987 (2010): 75-78. [cited by applicant]
Yu et al. “Chapter 3 MarkDuplicates: A practical introduction to GATK 4 on Biowulf.” GATK, 2021 [retrieved on Jun. 16, 2022]. Retrieved from the Internet: <URL:https://hpc.nih.gov/training/gatk_tutorial/markdup.html>, 6… [cited by applicant]
Yu et al. “Mung bean nuclease treatment increases capture specificity of microdroplet-PCR based targeted DNA enrichment.” Plos one 9.7 (2014): 1-7. [cited by applicant]
Zeerleder, S. “The struggle to detect circulating DNA.” Critical Care 10 (2006): 1-3. [cited by applicant]
Zheng et al. “Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies.” Genome biology 18 (2017): 1-14. [cited by applicant]
Griewank et al. “Genetic alterations and personalized medicine in melanoma: progress and future prospects.” Journal of the National Cancer Institute 106.2 (2014): 1-17. [cited by applicant]
Ju et al. “Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals.” Nature genetics, 43(8), pp. 745-752. Available at: https://doi.org… [cited by applicant]
Ju et al. “A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.” Genome Research, 22(3), pp. 436-445. Available at: https://doi.org/10.1101/gr.133645.1… [cited by applicant]
Seo et al. “The transcriptional landscape and mutational profile of lung adenocarcinoma.” Genome Research, 22(11), pp. 2109-2119. Available at: https://doi.org/10.1101/gr.145144.112. (2012). [cited by applicant]
Shah et al. “Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.” Nature, 461 (7265), pp. 809-813. Available at: https://doi.org/10.1038/nature08489. (2009). [cited by applicant]
Dawe et al. “Cell migration from baby to mother.” Cell adhesion & migration 1.1 (2007): 19-27. [cited by applicant]
Dawson et al. “Analysis of circulating tumor DNA to monitor metastatic breast cancer.” New England Journal of Medicine 368.13 (2013): 1199-1209. [cited by applicant]
De La Chapelle, A. “The incidence of Lynch syndrome.” Familial cancer 4 (2005): 233-237. [cited by applicant]
De Mattos-Arruda et al. “Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.” Annals of oncology 25.9 (2014): 1729-1735. [cited by applicant]
De Mattos-Arruda et al. “Circulating tumour cells and cell-free DNA as tools for managing breast cancer.” Nature reviews Clinical oncology 10.7 (2013): 377-389. [cited by applicant]
Decathelineau et al. “The final step in programmed cell death: phagocytes carry apoptotic cells to the grave.” Essays in biochemistry 39 (2003): 105-117. [cited by applicant]
Dewey et al. “Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.” PLoS genetics 7.9 (2011): 1-15. [cited by applicant]
Diaz et al. “Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA.” Oncotarget 4.10 (2013): 1856-1857. [cited by applicant]
Diaz et al. “Liquid biopsies: genotyping circulating tumor DNA.” Journal of clinical oncology 32.6 (2014): 579-586. [cited by applicant]
Diehl et al. “Detection and quantification of mutations in the plasma of patients with colorectal tumors.” Proceedings of the National Academy of Sciences 102.45 (2005): 16368-16373. [cited by applicant]
Ding et al. “Genome remodelling in a basal-like breast cancer metastasis and xenograft.” Nature 464.7291 (2010): 999-1005. [cited by applicant]
Dressman et al. “Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations.” Proceedings of the National Academy of Sciences 100.15 (2003): 8817-8822. [cited by applicant]
Drmanac et al. “Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays.” Science 327.5961 (2010): 78-81. [cited by applicant]
EcSeq. “How to calculate the coverage for a NGS experiment.” ecSeq Bioinformatics, 2019 [retrieved on Jul. 5, 2022]. Retrieved from the Internet: <URL:https://www.ecseq.com/support/ngs/how-to-calculate-the-coverage-for-… [cited by applicant]
Ellinger et al. “The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer.” Urologic Oncology: Seminars and Original Investigations, Elsevier 29.2 (2011): 124-129. [cited by applicant]
Elsharawy et al. “Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing.” BMC genomics 13 (2012): 1-14. [cited by applicant]
Elshimali et al. “The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.” International journal of molecular sciences 14.9 (2013): 18925-18958. [cited by applicant]
Esplin et al. “Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease.” Pharmacogenomics 15.14 (2014): 1771-1790. [cited by applicant]
Fahy et al. “Self-sustained sequence replication (3SR): an isothermal transcription-based amplification system alternative to PCR.” Genome Research 1.1 (1991): 25-33. [cited by applicant]
Fairbrother et al. “RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.” Nucleic acids research 32 (2004): W187-W190. [cited by applicant]
FASTQ Format, Encyclopedia [online], Wikipedia, 2000. Retrieved from the Internet: <URL:https://en.wikipedia.org/wiki/FASTQ_format>, 11 pages. [cited by applicant]
Fishel et al. “Meta-analysis of gene expression data: a predictor-based approach.” Bioinformatics 23.13 (2007): 1599-1606. [cited by applicant]
Fluidigm. “Specification Sheet for Access Array System.” Datasheet [online], Fluidigm, 2012, 4 pages. [cited by applicant]
Forshew et al. “Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.” Science translational medicine 4.136 (2012): 1-13. [cited by applicant]
Forshew et al. “Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.” Supplementary Materials. Science translational medicine 4.136 (2012): 1-20. [cited by applicant]
Fox et al. “Accuracy of next generation sequencing platforms.” Next generation, sequencing & applications 1 (2014): 1-9. [cited by applicant]
Freed et al. “Somatic mosaicism in the human genome.” Genes 5.4 (2014): 1064-1094. [cited by applicant]
Freshney, R. “Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications.” Sixth Edition, Hoboken, New Jersey, John Wiley & Sons (2010): 1-42. [cited by applicant]
Frumkin et al. “Genomic variability within an organism exposes its cell lineage tree.” PLoS computational biology 1.5 (2005): 382-394. [cited by applicant]
GATK. “Genome Analysis Toolkit: Variant Discovery in High-Throughput Sequencing Data.” Broad Institutes: GATK, 2025. Retrieved from the Internet: <URL:https://gatk.broadinstitute.org/hc/en-us>, 2 pages. [cited by applicant]
Gilbert, S. “Developmental Biology Tenth Edition.” Sunderland, MA, Sinauer Associates, Inc. (2014): 1-12. [cited by applicant]
Gnirke et al. “Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.” Nature biotechnology 27.2 (2009): 182-189. [cited by applicant]
Golob, J. “Mechanisms of cell fate acquisition in the differentiation of pluripotent stem cells.” University of Washington (2009): 1-126. [cited by applicant]
Goris et al. “The immunogenetic architecture of autoimmune disease.” Cold Spring Harbor perspectives in biology 4.3 (2012): 1-15. [cited by applicant]
Gottlieb et al. “The DiGeorge syndrome minimal critical region contains a goosecoid-like (GSCL) homeobox gene that is expressed early in human development.” American journal of human genetics 60.5 (1997): 1194-1201. [cited by applicant]
Guan et al. “Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer.” Chinese journal of cancer 31.10 (2012): 463-470. [cited by applicant]
Guo et al. “Exome sequencing generates high quality data in non-target regions.” BMC genomics 13 (2012): 1-10. [cited by applicant]
Guo et al. “Exome sequencing generates high quality data in non-target regions.” BMC genomics 13, Supplementary Tables, (2012): 1-803. [cited by applicant]
Guo et al. “Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.” Nature genetics 45.12 (2013): 1459-1463. [cited by applicant]
Haferlach et al. “Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype.” Leukemia 22.8 (2008): 1539-1541. [cited by applicant]
Hamfjord et al. “Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.” PloS one 7.4 (2012): 1-9. [cited by applicant]
Hiratani et al. “Replication timing and transcriptional control: beyond cause and effect part II.” Current opinion in genetics & development 19.2 (2009): 142-149. [cited by applicant]
Hirschhorn et al. “Human intersex with chromosome mosaicism of type XY/XO: Report of a case.” New England Journal of Medicine 263.21 (1960): 1044-1048. [cited by applicant]
Hohaus et al. “Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.” Annals of oncology 20.8 (2009): 1408-1413. [cited by applicant]
Holstege et al. “Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis.” Genome research 24.5 (2014): 733-742. [cited by applicant]
Hong et al. “Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.” Nature communications 6.1 (2015): 1-12. [cited by applicant]
Huang et al. “Characterization of human plasma-derived exosomal RNAs by deep sequencing.” BMC genomics 14 (2013): 1-14. [cited by applicant]
Huang et al. “Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.” Scientific reports 8.1 (2018): 1-8. [cited by applicant]
Huang et al. “SMuRF: portable and accurate ensemble prediction of somatic mutations.” Bioinformatics 35.17 (2019): 3157-3159. [cited by applicant]
Human Genome Overview GRCh37, Datasheet [online], Genome Reference Consortium, 2009 [retrieved on Sep. 12, 2022]. Retrieved from the Internet: <URL:https://www.ncbi.nlm.nih.gov/grc/human>, 2 pages. [cited by applicant]
Adessi et al. “Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms.” Nucleic acids research 28.20 (2000): 1-8. [cited by applicant]
Agilent. “SureSelectXT Target Enrichment System for the Illumina Platform.” Datasheet [online], Agilent Technologies, 2021. Retrieved from the Internet: <URL:https://www.agilent.com/cs/library/usermanuals/public/G7530-9… [cited by applicant]
Akey et al. “Haplotypes vs single marker linkage disequilibrium tests: what do we gain?” European Journal of Human Genetics 9.4 (2001): 291-300. [cited by applicant]
Albert et al. “Direct selection of human genomic loci by microarray hybridization.” Nature methods 4.11 (2007): 903-905. [cited by applicant]
Alter et al. “Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.” Journal of medical genetics 44.1 (2007): 1-9. [cited by applicant]
Anderson et al. “Next generation DNA sequencing and the future of genomic medicine.” Genes 1.1 (2010): 38-69. [cited by applicant]
Anonymous. “Cell Fate Map Adapted from Gilberts Developmental Biology, Fourth Edition, Figure 9.1.” Stack Exchange: Biology, Apr. 16, 2014. Retrieved from the Internet: <URL:https://biology.stackexchange.com/questions/1… [cited by applicant]
Anzar et al. “NeoMutate: an ensemble machine learning framework for the prediction of somatic mutations in cancer.” BMC medical genomics 12 (2019): 1-14. [cited by applicant]
ARUP. “Exome Sequencing Symptom-Guided Analysis.” ARUP Laboratories, 2013 [retrieved on Oct. 1, 2014]. Retrieved from the Internet: <URL:https://ltd.aruplab.com/Tests/Pub/2006332>, 2 pages. [cited by applicant]
Asan et al. “Comprehensive comparison of three commercial human whole-exome capture platforms.” Genome biology 12 (2011): 1-12. [cited by applicant]
Ausubel et al. “Current Protocols in Molecular Biology—Table of Contents.” New York, Greene Publishing Associates and Wiley-Interscience (1987): 1-8. [cited by applicant]
Bainbridge et al. “Whole exome capture in solution with 3 Gbp of data.” Genome biology 11 (2010): 1-8. [cited by applicant]
Baird et al. “Developing recombinant antibodies for biomarker detection.” Cancer Biomarkers 6.5-6 (2010): 271-279. [cited by applicant]
Bamshad et al. “Exome sequencing as a tool for Mendelian disease gene discovery.” Nature Reviews Genetics 12.11 (2011): 745-755. [cited by applicant]
BCL2FASTQ Conversion User Guide, Manual [online], Illumina, 2013. Retrieved from the Internet: <URL:https://support.illumina.com/content/dam/illumina-support/documents/documentation/software_documentation/bcl2fastq/bcl2… [cited by applicant]
Beck et al. “Profile of the circulating DNA in apparently healthy individuals.” Clinical chemistry 55.4 (2009): 730-738. [cited by applicant]
Behjati et al. “Genome sequencing of normal cells reveals developmental lineages and mutational processes.” Nature 513.7518 (2014): 422-425. [cited by applicant]
Benesova et al. “Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.” Analytical biochemistry 433.2 (2013): 227-234. [cited by applicant]
Bent et al. “Enriching pathogen transcripts from infected samples: a capture-based approach to enhanced host pathogen RNA sequencing.” Analytical Biochemistry 438.1 (2013): 90-96. [cited by applicant]
Bentley et al. “Accurate whole human genome sequencing using reversible terminator chemistry.” Nature 456.7218 (2008): 53-59. [cited by applicant]